“…As the genes encoding 17β‐HSD enzymes from mycobacterial species have not been identified and these proteins have been only partially purified and characterized (Goren et al ., 1983; Egorova et al ., 2002a, 2005), we initially selected as enzyme candidates for metabolic engineering the well‐described 17β‐HSDs from the bacterium C. testosteroni (Schultz et al ., 1977; Lefebvre et al .,1979; Minard et al ., 1985
; Genti‐Raimondi et al ., 1991; Yin et al ., 1991; Abalain et al ., 1993; Benach et al ., 1996, 2002; Oppermann et al ., 1997; Cabrera et al ., 2000) and the fungus C. lunatus (Plemenitas et al ., 1988; Rižner et al ., 1996, 1999, 2000, 2001a,b; Rižner and Zakelj‐Mavric, 2000; Zorko et al ., 2000; Kristan et al ., 2003, 2005, 2007a,b; Cassetta et al ., 2005; Ulrih and Lanisnik Rižner, 2006; Brunskole et al ., 2009; Svegelj et al ., 2012), because both enzymes present some relevant differences. Although they catalyse a reversible reaction and display similar reaction mechanisms, the reaction equilibrium of the fungal 17β‐HSD is shifted towards reduction, whereas the bacterial enzyme is shifted towards oxidation, as this enzyme is mainly involved into the TS catabolism in C. testosteroni (Genti‐Raimondi et al., 1990; Cabrera et al ., 2000).…”